Postoperative Seizure Prophylaxis in Intracranial Tumors: Evaluating the Role of Anti-Seizure Medication in Seizure-Naïve Patients
Current Neurology and Neuroscience Reports · 20.07.2026 · 26 (1)
DOI: 10.1007/s11910-026-01503-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Neurology and Neuroscience Reports, online erschienen am 20.07.2026. Verfasst von Nitish Seenarine und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, State University of New York Downstate Health Sciences University, 445 Lenox Road, Brooklyn, NY, 11203, USA. Hauptthemen laut MEDLINE: Anticonvulsants, Brain Neoplasms, Seizures, Postoperative Complications. Die Arbeit nennt 130 Literaturangaben.
Abstract (Originalsprache)
PURPOSE OF REVIEW: Postoperative seizures occur in up to 20% of seizure-naïve adult patients undergoing craniotomy for tumor resection, contributing to morbidity and readmissions. Yet, routine prophylactic use of anti-seizure medications (ASMs) in this population remains unsupported by current evidence-based guidelines. In this review, we synthesize current evidence on seizure incidence, timing, risk factors, and practical perioperative management strategies. RECENT FINDINGS: Postoperative seizure risk varies by tumor type, cortical involvement, peritumoral edema, hemorrhage, and tumor grade. Across randomized trials and meta-analyses, prophylactic ASM administration has not been shown to consistently reduce postoperative seizure incidence, and older agents can increase toxicity and interaction risk. Some studies suggest a modest reduction of early seizures within the first postoperative week, though this benefit is not sustained long-term. When prophylaxis is employed, second-generation ASMs such as levetiracetam are often favored for their higher tolerability and fewer drug-drug interactions compared to older agents. Emerging evidence has described alternative agents to levetiracetam with greater blood-brain-barrier permeability, but further investigation is required. Routine ASM prophylaxis in seizure-naïve patients undergoing intracranial tumor resection is not supported by current evidence or clinical guidelines. A selective, risk-based approach with short-term prophylaxis may be considered in patients with high-risk features. Future prospective, risk-stratified trials are needed to better define subgroups that may benefit from targeted prophylactic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, State University of New York Downstate Health Sciences University, 445 Lenox Road, Brooklyn, NY, 11203, USA.
- Northwell, 270-05 76th Avenue, New Hyde Park, NY, 11040, USA.
- Department of Neurosurgery, Northwell Health, Donald and Barbara, Zucker School of Medicine at Hofstra/Northwell, 130 E 77th Street #3, New York, NY, 10075, USA.
- Northwell, 270-05 76th Avenue, New Hyde Park, NY, 11040, USA. rdamico8@northwell.edu.
- Department of Neurosurgery, Northwell Health, Donald and Barbara, Zucker School of Medicine at Hofstra/Northwell, 130 E 77th Street #3, New York, NY, 10075, USA. rdamico8@northwell.edu.
ORCID-Profile: Nitish Seenarine, Samuel Latzman, Shoaib Syed, Randy S D'Amico
Zitieren
APA
Seenarine, N., Latzman, S., Mittelman, L., Zhigin, V., Hirowski, E., Syed, S., Sy, H., & D'Amico, R. S. (2026). Postoperative Seizure Prophylaxis in Intracranial Tumors: Evaluating the Role of Anti-Seizure Medication in Seizure-Naïve Patients. Current Neurology and Neuroscience Reports, 26(1). https://doi.org/10.1007/s11910-026-01503-4
Vancouver
Seenarine N, Latzman S, Mittelman L, Zhigin V, Hirowski E, Syed S, et al. Postoperative Seizure Prophylaxis in Intracranial Tumors: Evaluating the Role of Anti-Seizure Medication in Seizure-Naïve Patients. Current Neurology and Neuroscience Reports. 2026;26(1). doi:10.1007/s11910-026-01503-4
BibTeX
@article{Seenarine2026,
author = {Seenarine, Nitish and Latzman, Samuel and Mittelman, Laura and Zhigin, Vadim and Hirowski, Emily and Syed, Shoaib and Sy, Heustein and D'Amico, Randy S},
title = {Postoperative Seizure Prophylaxis in Intracranial Tumors: Evaluating the Role of Anti-Seizure Medication in Seizure-Naïve Patients},
journal = {Current Neurology and Neuroscience Reports},
year = {2026},
volume = {26},
number = {1},
doi = {10.1007/s11910-026-01503-4}
}
EUVIMED